Point of Care Testing (POCT): defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care.[1][2] This contrasts with the historical pattern in ...

Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...

LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

Diagnostic and treatment monitoring protocols for a range of disorders rely on measuring specific blood parameters, such as blood sugar. The determination of these levels has traditionally been ...

Point-of-care testing in community pharmacies is becoming more common, according to a new report by the International Pharmaceutical Federation, which also cited challenges that remain to be addressed ...

The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...

DUBLIN, June 17, 2019 /PRNewswire/ -- The "Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The "US Point-of-Care Testing Infectious Disease Market, Forecast to 2022" report has been added to ResearchAndMarkets.com's offering. Management of infectious diseases remains a critical challenge ...

WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...